In the News
GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer
GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, announced on May 31 that it has entered into a definitive agreement to combine with Cirina, Ltd., another company focused on early detection of cancer. The work of Hong Kong-based Cirina has been part of a growing body...
Dementia Products Are Now Available to Buy on the High Street For the Very First Time
Unforgettable, the UK’s leading authority on dementia services, has teamed up with Lloyds Pharmacy to provide a range of dementia aide products to Lloyds customers. The collection includes seven products designed to make the lives of dementia patients and their caretakers easier, such as a 2-in-1 day clock, an easy...
Shop Targets Dementia Sufferers With Talking Clocks and Jigsaws
Lloyds Pharmacy has begun stocking products for people with dementia. The store chain will sell seven items made by Unforgettable in 59 of its stores, with more Unforgettable products available on the Lloyds Pharmacy website. The items to be sold include a talking alarm clock that can record messages for up to six...
University of Miami Health System Selects Kyruus ProviderMatch™ to Optimize Patient Experience Across Its Call Center and Website
The University of Miami Health Systems, also known as UHealth, will be using the ProviderMatch™ system to enhance patient experience and increase accessibility. ProviderMatch™, from big data company Kyruus, is designed to deliver a consistent patient experience across various points of access. The multi-channel...
There’s an “Arms Race” in Early Cancer Detection Start-Ups, and SoftBank Just Plowed $360 Million into One of Them
The liquid biopsy space is increasingly full of up-and-coming new companies hoping to pave the way for an enhanced set of diagnostic tests and treatments for cancer. But this kind of technology, while more possible scientifically than ever before, requires a huge amount of funding. That’s why the news lately has been...
With $360M in New Financing, Guardant Health Prepares to Sequence One Million Cancer Patients
Guardant Health, based in Redwood, California, has secured $360 million in investor financing, making it the newest horse in the race to use liquid biopsy technology to significantly advance cancer testing and treatment. Guardant will use this round of financing to expand its work both nationally and internationally,...
Guardant Health Raises $360 Million in Race to Create Cancer Blood Tests
Guardant Health, a California-based biotechnology company that sells blood tests to track and detect cancer, recently announced a $360 million round of funding, which has been earmarked to support Guardant’s ambitious goal to test one million patients over the next five years. This massive amount of funding isn’t...
US Venture Capital Fund McKesson Ventures Leads £2.25M Investment in UK Dementia Start-Up Unforgettable.org
Unforgettable.org, a UK-based dementia start-up, just earned a £2.25M in an investment round led by US-based venture capital firm McKesson Ventures. There are currrently 47 million people in the world living with dementia, 850,000 of which live in the UK. And if the latest calculations prove to be correct, there will...
US Venture Capital Fund McKesson Ventures Leads £2.25M Investment in UK Tech City Dementia Start-Up Unforgettable.org
In its first investment outside North America, McKesson Ventures has invested in British start-up Unforgettable.org. Unforgettable.org provides more than 1,000 simple solutions on its website to make dementia sufferers’ lives easier, as well as supporting their caregivers through advice and an online community. As a...
110 women in medtech to know in 2017
Becker’s Hospital Review has released a list of 100 leading female figures in the medical technology (medtech) industry. Here are just a few of the women honored on the 2017 list: Kathryn E. Wengel, Worldwide Vice President of Johnson & Johnson Supply Chain and Chief Supply Chain Officer of Johnson & Johnson...
Press Releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.